CME/CE Activity

The National Kidney Foundation (NKF) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), an accredited provider by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation, an accredited provider by the Commission on Dietetic Registration (CDR) and an accredited provider by the Association for Social Work Boards (ASWB) to provide continuing education to physicians, nurses/dialysis technicians, dietitians and social workers respectively. In addition, individual activities are approved on an activity specific basis for family physicians, advanced practitioners (nurse practitioners and physician assistants), pharmacists, certified case managers, transplant coordinators, and other specialties.

System Requirements for Participation

Substance Abuse: A 2015 Primer

Available through: Aug 25, 2016

This continuing education activity is designed to help nephrology social workers detect and assess substance abuse in patients with chronic kidney disease or kidney failure. The new DSM-5 diagnostic criteria for substance use disorders will be explained and reviewed.  Participants will learn about the different classes of abused substances and their physiological and psychological impact on this population, with a special emphasis on the newer substances of abuse.  Screening and assessment tools to help determine an appropriate intervention and treatment plan will be presented.

Approved for: 1.5 **
Faculty: Jane Kwatcher, MSW, LCSW; Mathais Stricherz, EdD

Are Electrolytes Really Important?

Available through: Aug 25, 2016

This activity will address maintenance of sodium balance during fluid removal in dialysis treatments. Treatment strategies for addressing imbalances of sodium and other electrolytes as well as associated pathologies will also be discussed.

Approved for: 1.5 **
Faculty: Jeff Giullian, MD, MBA

Dialysis Access: A Fragile Lifeline

Available through: Aug 25, 2016

This activity will address the tale of the neglected aneurysm, the pros and cons of forearm arteriovenous graft (AVG) before upper arm arteriovenous fistula (AVF), and the pros and cons of buttonhole cannulation.  

Approved for: 1.5 **
Faculty: Michael Allon, MD; Charmaine Lok, MD, MSc, FNKF; Tushar Vachharajani, MD, FASN, FACP

Connecting Hospice, Dialysis, and Healthcare Reform

Available through: Aug 25, 2016

The goal of this program is to encourage the early incorporation of hospice and palliative care discussions in care planning, and to underscore the need for, and benefits of, closer collaboration between hospices and dialysis clinics in the context of healthcare reform.

Approved for: 1.5 **
Faculty: Carlos T. Gravern

The Potassium Challenge in CKD: Managing Acute & Chronic Hyperkalemia (A Knowledge-Based Program)

Available through: Jun 26, 2017

This CME/CE Activity focuses on the pathophysiologic consequences of hyperkalemia, the limitations of current therapeutic strategies, and the risks associated with suboptimal dosing or discontinuation of RAAS therapy as a result of persistent hyperkalemia.

Approved for: 1.5 **
Faculty: Robert D. Toto, MD; Peter McCullough, MD, MPH, FNKF; Kamyar Kalantar-Zedeh, MD, MPH, PhD

Getting Ahead of Metabolic and Mineral Disturbances in the Management of CKD-MBD: A Focus on Management Strategies

Available through: Jun 25, 2016

This activity will review the pathophysiology of mineral and bone disorder in chronic kidney disease (CKD-MBD), as well as its relationship to cardiovascular risk and other comorbidities.  Current and emerging strategies to proactively manage CKD-MBD will be explored.

Approved for: 1.5 **
Faculty: Kathleen Hill Gallant, PhD, RD; Ellie Kelepouris, MD, FAHA; Rajnish Mehrotra, MD, FNKF

Pathogenesis and Management of Nephrotic Syndrome in Primary Podocytopathies (A knowledge-based program)

Available through: Jun 26, 2017

This CME/CE Activity will address the ongoing medical problem of nephrotic syndrome, including the management of proteinuria. Content will review the pathogenesis and etiologies of nephrotic syndrome. Evaluation, management strategies, and treatment options will also be addressed.

Approved for: 1.5 **
Faculty: Faculty: Laurence Beck, MD, PhD, Brad Rovin, MD, Fernando Fervenza, MD, PhD

Challenges in Lipid Management: Addressing the High-Risk Patient and the Potential for Novel Therapies (A Knowledge-based Program)

Available through: Feb 27, 2017

This CME/CE Activity will address clinical gaps and barriers to optimal lipid management, and how to manage high-risk patients. An overview of research on novel therapies, such as PCSK9 inhibitors, will also be discussed. This activity will include online slide presentations with 3-D animated simulation segments to actively educate and engage participants.

Approved for: 1.0 **
Faculty: Martin Quan, MD, Karol E. Watson, MD, PhD, Christie M. Ballantyne, MD

NKF Kidney Talks Video Series

Available through: Aug 15, 2016

This CME/CE NKF Kidney Talks Learning Activity enables the participant to learn from renowned speakers through short, visually engaging animated presentations. This program is comprised of three stand-alone video presentations that inform clinicians of current science about treating proteinuria as it relates to membranous nephropathy.

Membranous Nephropathy: New Insights Regarding Pathogenesis

Membranous Nephropathy: New Insights Regarding Diagnosis

Membranous Nephropathy: New Insights Regarding Treatment

Approved for: Each course is approved for .25 **
Faculty: Laurence H. Beck, Jr., MD, PhD; Fernando C. Fervenza, MD, PhD

Heart-Kidney Interaction & the Role of Vasopressin and Hyponatremia in Heart Failure

Available through: Aug 15, 2016

This program will address the common medical problem of hyponatremia in heart failure (HF), and its clinical management in the presence of kidney disease. Content will review mechanistic responses to disequilibrium in the heart-kidney interaction that lead to alterations in water and sodium balance, the role of vasopressin in the pathogenesis of hyponatremia, and the relationship between hyponatremia and mortality risk. Expert faculty will address differential diagnosis, evaluation and treatment of hyponatremia in HF patients, and will provide insight into clinical evidence for available treatment options, including the benefits and limitations of vasopressin receptor antagonists.

Approved for: 1.5 **
Faculty: Mathew R. Weir, MD; Joseph G. Verbalis, MD; James E. Udelson, MD

Clinical Aspects of Fibroblast Growth Factor 23 in Chronic Kidney Disease

Available through: Aug 15, 2016

This program will provide current information about the emerging clinical significance of fibroblast growth factor 23 (FGF23), a major modifier of bone mineral metabolism. Studies linking FGF23 to adverse renal and cardiovascular outcomes in patients with chronic kidney disease (CKD) will be discussed.

Approved for: 1.5 **
Faculty: Csaba P. Kovesdy, MD, FASN; Myles S. Wolf, MD, MMSc; Orlando M. Gutierrez, MS, MMSc

New Insights Into the Role of Phosphorus Balance in Chronic Kidney Disease

Available through: Aug 15, 2016

This program will improve learners’ strategies for managing serum phosphorus and anemia in patients with chronic kidney disease (CKD) or kidney failure.

Approved for: 1.5 **
Faculty: Myles S. Wolf, MD, MMSc; Geoffrey A. Block, MD, CCRI; Sylvia E. Rosas, MD, MSCE, FNKF

A New Era In PKD Management: Strategies In Delaying Progression

Available through: Sep 15, 2015

This activity will actively engage learners in evaluating their knowledge of and practice in polycystic kidney disease (PKD), identifying areas for improvement, and planning to make positive changes to delay disease progression and improve outcomes.

Approved for: 1.5 **
Faculty: Charles L. Edelstein, MD, PhD, FAHA; Arlene Chapman, MD; Benjamin D. Cowley, Jr., MD

Hemoglobin Variability: Individualization of Anemia Management for the Patient with End Stage Renal Disease

Available through: Sep 15, 2015

This program will review the evaluation and management of hemoglobin variability in patients with dialysis-related anemia. Strategies to optimize and individualize anemia therapy for patients on dialysis will be discussed.

Approved for: 1.5 **
Faculty: Anil K. Agarwal, MD, FACP, FASN, FN; Lynda Szczech, MD; Jay B. Wish, MD

Approaches to Membranous Nephropathy

Available through: Sep 15, 2015

This web-based program will help participants:
1) Review current research and clinical findings in the pathophysiology of membranous nephropathy (MN).
2) Examine novel diagnostic tools and management options in membranous lupus nephropathy (MLN) in order to differentiate MLN from the other glomerular diseases, and to understand its unique requirements.
3) Identify current therapeutic options in MN in order to individualize patient care with the most appropriate regimen.

Approved for: 1.5 **
Faculty: Fernando C. Fervenza, MD, PhD, FNKF; Joanne M. Bargman, MD, FRCPC; Laurence Beck, Jr., MD, PhD

Journal of Renal Nutrition (JRN) Online CPE Program

Available through:

Available through: Each article is available for credit for two (2) years from its original posting.

This web-based series of CPE activities is based on single articles published in the Journal of Renal Nutrition (JRN). 

Approved for: Varies (1.0 or 2.0) **
Faculty: Varies